Abstract
Pseudophakic macular edema (PME) is typically treated with nonsteroidal anti-inflammatory drugs (NSAIDs) initially, followed by steroids. Treatment with steroids becomes challenging in steroid responders. We report a case of PME treated with intravitreal methotrexate (Mtx) in a steroid responder. A 54-year-old-male underwent anterior vitrectomy with secondary intraocular-lens implantation following an eventful cataract surgery. Topical steroids given as a postoperative regimen led to severe steroid response and therefore were replaced by NSAIDs. Intraocular pressure was controlled by antiglaucoma drugs. Furthermore, he developed cystoid macular edema (CME). Since steroids were contraindicated, he was administered two intravitreal injections of Mtx 15 days apart, resulting in resolution of CME and restoration of vision.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
